» Authors » Cristina Aurigemma

Cristina Aurigemma

Explore the profile of Cristina Aurigemma including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 154
Citations 807
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bianchini F, Romagnoli E, Aurigemma C, Paraggio L, Buffon A, Fracassi F, et al.
JACC Cardiovasc Interv . 2025 Mar; PMID: 40071321
Background: "Stepwise provisional stenting" is the most adopted approach for percutaneous coronary interventions (PCI) in bifurcation lesions. During these procedures, side-branch (SB) may deserve treatment, but the best ballooning technique...
2.
Kovacevic M, Burzotta F, Stankovic G, Chieffo A, Milasinovic D, Cankovic M, et al.
Minerva Cardiol Angiol . 2025 Mar; 73(1):77-85. PMID: 40040499
Background: Current evidence on the long-term outcome and its determinants in patients with unprotected left main trifurcation (LMT) treated with percutaneous coronary intervention (PCI) is based on small-sized studies. We...
3.
Pieri M, Iannaccone M, Burzotta F, Botti G, Aurigemma C, Trani C, et al.
Front Cardiovasc Med . 2025 Jan; 11:1509162. PMID: 39886617
Although mortality risk prediction in cardiogenic shock (CS) is possible, assessing the impact of the multitude of therapeutic efforts on outcomes is not straightforward. We assessed whether a temporary mechanical...
4.
Aurigemma C, Trani C, DErrigo P, Barbanti M, Biancari F, Tarantini G, et al.
J Clin Med . 2025 Jan; 14(2). PMID: 39860611
Paravalvular leak (PVL) was initially recognized as one of the most common complications after transcatheter aortic valve implantation (TAVI) and has been linked to adverse clinical outcomes, including mortality. This...
5.
Galante D, Vicere A, Pollio Benvenuto C, Viccaro V, Giuliana C, Todisco S, et al.
J Cardiovasc Med (Hagerstown) . 2025 Jan; 26(2):72-80. PMID: 39841912
Aims: Coronary microvascular dysfunction (CMD) is a heterogeneous condition defined by reduced coronary flow reserve (CFR). The new index 'microvascular resistance reserve' (MRR) has been developed, but its role is...
6.
Galante D, Vicere A, Marrone A, Verardi F, Viccaro V, Giuliana C, et al.
Int J Cardiol . 2025 Jan; 422:132978. PMID: 39800227
Aims: To investigate the influence of index of microcirculatory resistance (IMR) on fractional flow reserve (FFR) and adenosine-induced hyperemia (ΔPd/Pa-FFR) in patients with chronic (CCS) or stabilized acute coronary syndromes...
7.
Leone A, Galante D, Vicere A, Marrone A, Verardi F, Giuliana C, et al.
Eur Heart J . 2025 Jan; 46(10):978-980. PMID: 39791532
No abstract available.
8.
Cappannoli L, Colantuono S, Animati F, Fracassi F, Galli M, Aurigemma C, et al.
Biomolecules . 2024 Oct; 14(10). PMID: 39456262
Acetylsalicylic acid (ASA) represents a cornerstone of antiplatelet therapy for the treatment of atherosclerotic coronary artery disease (CAD). ASA is in fact indicated in case of an acute coronary syndrome...
9.
Romagnoli E, Bianchini F, Aurigemma C, Zito A, Bianchini E, Paraggio L, et al.
Int J Cardiol Heart Vasc . 2024 Oct; 55:101523. PMID: 39445119
Background: Trans-femoral (TF) represents the main access for TAVI. Although there are various technical strategies to conduct TF-TAVI (pacing modality, secondary arterial access, primary access puncture etc.), the optimal technique...
10.
Paraggio L, Bianchini F, Aurigemma C, Romagnoli E, Bianchini E, Zito A, et al.
Circ Cardiovasc Interv . 2024 Aug; 17(9):e014156. PMID: 39166330
Transfemoral access is nowadays required for an increasing number of percutaneous procedures, such as structural heart interventions, mechanical circulatory support, and interventional electrophysiology/pacing. Despite technological advancements and improved techniques, these...